| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/16/2001 | US6174997 Antibody which specifically binds polypeptide of defined amino acid sequence; diagnosis of non-hodgkin's lymphoma; anticarcinogenic agents |
| 01/16/2001 | US6174996 Fusion protein with reduced side effects; for use as viricides, anticarcinogenic/antitumor/antiproliferative agents in humans and animals; feline leukemia virus; human immunodeficiency virus; hepatitis b and c viruses |
| 01/16/2001 | US6174995 Amino acid sequences of chemokine beta-4 and monocyte chemotactic protein-4; anticarcinogenic/antitumor agents; antifibrotic/antiarthritic/antiinflammatory agents; treatment of chronic infections, autoimmune disorders, psoriasis |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |
| 01/16/2001 | US6174992 Amino acid sequence; anticarcinogenic/antitumor agents; antiinflammatory agents; treatment of asthma, rhinitis, cystic fibrosis, and atopy; diagnosis; inhibits phospholipase a2; binds chlorinated biphenyl; inhibits platelet aggregation |
| 01/16/2001 | US6174872 Immunotherapy of allergic asthma in both its early and late stages by administering to the mucosa a polynucleotide encoding an asthma-initiating antigen and immunostimulatory neucleotide seqence stimulating the th1 lymhocytes |
| 01/16/2001 | US6174871 Gene therapies for enhancing cardiac function |
| 01/16/2001 | US6174868 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 01/16/2001 | US6174862 Neuroprotectant administered to patients suffering from alzheimer's disease, human immunodeficiency virus |
| 01/16/2001 | US6174861 Administering anticarcinogenic/antitumor agent |
| 01/16/2001 | US6174860 Nucleic acid isolated from a nematode symbiotic bacterium |
| 01/16/2001 | US6174858 Conjugates useful in the treatment of prostate cancer |
| 01/16/2001 | US6174725 Plant or seed having a dna sequence encoding a high molecular weight glutenin subunit having from 10 to 150 repeats of defined sequence operably linked to a promoter; for bread and noodles |
| 01/16/2001 | US6174721 Protein having kunitz-type domains of tissue factor pathway inhibitors and lacking glycosylation sites; for prevention and treatment of septic shock |
| 01/16/2001 | US6174717 Elicitor of the hypersensitive response in plants |
| 01/16/2001 | US6174714 Lyss |
| 01/16/2001 | US6174705 Polypeptides and dna (rna) encoding such polypeptides by recombinant techniques; for the treatment of infection, particularly fungal infections |
| 01/16/2001 | US6174702 Human pinch protein homolog |
| 01/16/2001 | US6174701 Neuronal factor |
| 01/16/2001 | US6174700 Purification of a polypeptide compound having a polysaccharide binding domain by affinity phase separation |
| 01/16/2001 | US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding |
| 01/16/2001 | US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance |
| 01/16/2001 | US6174689 Viral encoded semaphorin protein receptor DNA and polypeptides |
| 01/16/2001 | US6174685 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/16/2001 | US6174679 CIF150/hTAFII150 is necessary for cell cycle progression |
| 01/16/2001 | US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases |
| 01/16/2001 | US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning |
| 01/16/2001 | US6174666 Reducing adjustments in ribonucleic acid sequences; providing gene coding transcription products, detect regulatory sequences, insert point mutations, transfect mutated gene into cells, culture cells and monitoring gene expression |
| 01/16/2001 | US6174532 L2 immunogenic peptides of papillomavirus |
| 01/16/2001 | US6174528 Inducing protective antibodies against group a streptococci |
| 01/16/2001 | US6174527 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/16/2001 | CA2164707C Technetium-99m labeled peptides for imaging inflammation |
| 01/16/2001 | CA2093659C Dna sequence encoding bovine .alpha.-lactalbumin and methods of use |
| 01/16/2001 | CA2076979C Substantially pure transforming growth factor-.beta.-1-binding protein and nucleotide sequences expressing the binding protein |
| 01/16/2001 | CA2029861C Diagnosis and treatment of insulin dependent diabetes mellitus |
| 01/16/2001 | CA2010800C Protein labelling |
| 01/16/2001 | CA1341172C Synthetic insecticidal crystal protein gene |
| 01/16/2001 | CA1341170C Calcium channel compositions and methods |
| 01/16/2001 | CA1341169C Factor viii analog, process for its preparation and composition containing it |
| 01/16/2001 | CA1341166C Antigenic proteins and vaccines containing them for prevention of coccidiosis |
| 01/16/2001 | CA1341165C Active site modified protease alpha-1-antitrypsin inhibitors and their production |
| 01/11/2001 | WO2001002897A1 System, apparatus, and method for correcting vision using electro-active spectacles |
| 01/11/2001 | WO2001002895A1 System, apparatus, and method for correcting vision using an electro-active lens |
| 01/11/2001 | WO2001002863A1 Diagnostic assay for human matrix gla-protein and its use as a biomarker |
| 01/11/2001 | WO2001002860A1 Snail, new tumoral progression marker and target protein of new antitumoral compounds |
| 01/11/2001 | WO2001002856A1 Method for determination of peptide-binding agent interaction |
| 01/11/2001 | WO2001002609A2 Method of identifying toxic agents using differential gene expression |
| 01/11/2001 | WO2001002607A1 Adenovirus carrying gag gene hiv vaccine |
| 01/11/2001 | WO2001002604A1 Use of the krit1 gene in angiogenesis |
| 01/11/2001 | WO2001002601A2 Cell-based assay systems for examining hcv ns3 protease activity |
| 01/11/2001 | WO2001002594A2 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER |
| 01/11/2001 | WO2001002592A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 01/11/2001 | WO2001002590A2 Plants with modified gene expression |
| 01/11/2001 | WO2001002587A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/11/2001 | WO2001002579A1 SYNTHETIC cryIC GENE AND TRANSGENIC PLANTS EXPRESSING SAME |
| 01/11/2001 | WO2001002578A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | WO2001002577A1 Pseudomonas aeruginosa antigens |
| 01/11/2001 | WO2001002576A1 The lactose operon of lactobacillus delbrueckii and its use for controlling gene transcription and/or expression in bacterial cells |
| 01/11/2001 | WO2001002575A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2001002574A1 Negative regulators of systemic acquired resistance |
| 01/11/2001 | WO2001002573A1 Genetic control of flowering using the fwa gene |
| 01/11/2001 | WO2001002572A1 Genetic control of flowering using the fwa gene |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002570A1 Delivery of trefoil peptides |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002568A2 Human genes and gene expression products |
| 01/11/2001 | WO2001002567A1 16405 receptor, a g-protein coupled receptor |
| 01/11/2001 | WO2001002566A1 Metabotropic glutamate receptors and methods of use therefor |
| 01/11/2001 | WO2001002565A2 Secreted protein zacrp4 |
| 01/11/2001 | WO2001002564A1 Novel polypeptide and dna thereof |
| 01/11/2001 | WO2001002563A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 01/11/2001 | WO2001002562A1 Placental organic anion transporter and gene thereof |
| 01/11/2001 | WO2001002561A2 Mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | WO2001002560A1 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 01/11/2001 | WO2001002557A1 Neurotrophic factor receptor |
| 01/11/2001 | WO2001002556A2 Agents for the diagnosis, prognosis and treatment of malignant diseases |
| 01/11/2001 | WO2001002552A2 Double transgenic animals as models for neurodegenerative disease |
| 01/11/2001 | WO2001002551A2 Virus like particles, preparation and use in screening and functional genomics |
| 01/11/2001 | WO2001002550A2 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | WO2001002549A2 Homomeric and heteromeric ampa receptors |
| 01/11/2001 | WO2001002440A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 01/11/2001 | WO2001002439A1 Neovascular-targeted immunoconjugates |
| 01/11/2001 | WO2001002438A1 Means of stabilizing hemoglobins |
| 01/11/2001 | WO2001002437A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 01/11/2001 | WO2001002436A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 01/11/2001 | WO2001002435A1 Method for stabilising proteins in complex mixtures during their storage in aqueous solvents |
| 01/11/2001 | WO2001002434A1 Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor |
| 01/11/2001 | WO2001002433A1 Keratinocyte growth factor-2 |
| 01/11/2001 | WO2001002432A1 Sh3-containing protein, dna and uses thereof |
| 01/11/2001 | WO2001002430A2 Arabidopsis thaliana cdc7 and cdc27 homologs |
| 01/11/2001 | WO2001002429A2 Angiopoietin-6 and uses thereof |
| 01/11/2001 | WO2001002426A1 A substantially crystalline form of melagatran |
| 01/11/2001 | WO2001002425A2 Peptide conjugates for the stabilization of membrane proteins and interactions with biological membranes |
| 01/11/2001 | WO2001002424A2 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 01/11/2001 | WO2001002370A1 Nickel-based reagents for detecting dna and dna-protein contacts |
| 01/11/2001 | WO2001002019A2 Control of gene expression |
| 01/11/2001 | WO2001002017A2 Erythropoietin conjugates with polyethylenglycol |
| 01/11/2001 | WO2001002008A1 Control of acidosis |
| 01/11/2001 | WO2001002005A2 Treatment of dentritic cells for induction of immune tolerance |